The COVID-19 pandemic highlights the need for an overhaul of the government's regulatory system for animal biotechnology products, the Biotechnology Innovation Organization said in a letter to President Donald Trump Tuesday.
To view this article, please
login. If you are not a current subscriber, you may sign up for a trial or view other subscription options
here.